These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 38460823)
1. Pentaerythrityl tetranitrate improves the outcome of children born to mothers with compromised uterine perfusion-12-months follow-up and safety data of the double-blind randomized PETN trial. Groten T; Lehmann T; Städtler M; Komar M; Winkler JL; Condic M; Strizek B; Seeger S; Jäger Y; Pecks U; Eckmann-Scholz C; Kagan KO; Hoopmann M; von Kaisenberg CS; Hertel B; Tauscher A; Schrey-Petersen S; Friebe-Hoffmann U; Lato K; Hübener C; Delius M; Verlohren S; Sroka D; Schlembach D; de Vries L; Kraft K; Seliger G; Schleußner E; Am J Obstet Gynecol MFM; 2024 Apr; 6(4):101332. PubMed ID: 38460823 [TBL] [Abstract][Full Text] [Related]
2. Effect of pentaerythritol tetranitrate (PETN) on the development of fetal growth restriction in pregnancies with impaired uteroplacental perfusion at midgestation-a randomized trial. Groten T; Lehmann T; Städtler M; Komar M; Winkler JL; Condic M; Strizek B; Seeger S; Jäger Y; Pecks U; Eckmann-Scholz C; Kagan KO; Hoopmann M; von Kaisenberg CS; Brodowski L; Tauscher A; Schrey-Petersen S; Friebe-Hoffmann U; Lato K; Hübener C; Delius M; Verlohren S; Sroka D; Schlembach D; de Vries L; Kraft K; Seliger G; Schleußner E; Am J Obstet Gynecol; 2023 Jan; 228(1):84.e1-84.e12. PubMed ID: 35931132 [TBL] [Abstract][Full Text] [Related]
3. Impact of the nitric oxide-donor pentaerythrityl-tetranitrate on perinatal outcome in risk pregnancies: a prospective, randomized, double-blinded trial. Schleussner E; Lehmann T; Kähler C; Schneider U; Schlembach D; Groten T J Perinat Med; 2014 Jul; 42(4):507-14. PubMed ID: 24421214 [TBL] [Abstract][Full Text] [Related]
4. Does Pentaerytrithyltetranitrate reduce fetal growth restriction in pregnancies complicated by uterine mal-perfusion? Study protocol of the PETN-study: a randomized controlled multicenter-trial. Groten T; Lehmann T; Schleußner E; BMC Pregnancy Childbirth; 2019 Sep; 19(1):336. PubMed ID: 31521118 [TBL] [Abstract][Full Text] [Related]
5. Pentaerythrityltetranitrate (PETN) improves utero- and feto-placental Doppler parameters in pregnancies with impaired utero-placental perfusion in mid-gestation - a secondary analysis of the PETN-pilot trial. Bowkalow S; Schleussner E; Kähler C; Schneider U; Lehmann T; Groten T J Perinat Med; 2018 Nov; 46(9):1004-1009. PubMed ID: 29272253 [TBL] [Abstract][Full Text] [Related]
6. A liquid chromatographic-mass spectrometric procedure for analysis of pentaerythrityl tetranitrate metabolites - Development, validation and application to ovine serum and human plasma samples. Städtler M; Wissenbach D; Wissenbach DK; Franke L; Pastuschek J; Schleussner E; Allison B; Peters FT; Groten T J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Feb; 1234():124028. PubMed ID: 38330519 [TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
8. Gestational age at birth, birth weight, and gestational age when intrauterine brain sparing occurs determines the neonatal outcome in growth-restricted infants born before 32 weeks of gestation: a retrospective cohort analysis. Köber F; Heimann Y; Lehmann T; Schleußner E; Proquitté H; Groten T Front Pediatr; 2024; 12():1377982. PubMed ID: 39026938 [TBL] [Abstract][Full Text] [Related]
9. Maternal treatment of spontaneously hypertensive rats with pentaerythritol tetranitrate reduces blood pressure in female offspring. Wu Z; Siuda D; Xia N; Reifenberg G; Daiber A; Münzel T; Förstermann U; Li H Hypertension; 2015 Jan; 65(1):232-7. PubMed ID: 25385760 [TBL] [Abstract][Full Text] [Related]
10. Cardiovascular health of women 10 to 20 years after placenta-related pregnancy diseases considering the possible effect of pentaerythrityl tetranitrate treatment during pregnancy on long-term maternal cardiovascular health (PAVA study). Lößner C; Multhaup A; Bäz L; Lehmann T; Heimann Y; Schleußner E; Franz M; Groten T PLoS One; 2024; 19(10):e0309177. PubMed ID: 39405308 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of the long-acting nitro vasodilator pentaerithrityl tetranitrate in patients with chronic stable angina pectoris receiving anti-anginal background therapy with beta-blockers: a 12-week, randomized, double-blind, placebo-controlled trial. Münzel T; Meinertz T; Tebbe U; Schneider HT; Stalleicken D; Wargenau M; Gori T; Klingmann I; Eur Heart J; 2014 Apr; 35(14):895-903. PubMed ID: 24071762 [TBL] [Abstract][Full Text] [Related]
12. NO-donors, part X [1] : investigations on the stability of pentaerythrityl tetranitrate (PETN) by HPLC-chemoluminescence-N-detection (CLND) versus UV-detection in HPLC. Seeling A; Lehmann J J Pharm Biomed Anal; 2006 Mar; 40(5):1131-6. PubMed ID: 16257501 [TBL] [Abstract][Full Text] [Related]
13. Poisoning of a dog with the explosive pentaerythrityl tetranitrate. Potocnjak D; Barić-Rafaj R; Lemo N; Matijatko V; Kis I; Mrljak V; Harapin I J Small Anim Pract; 2008 Jun; 49(6):314-8. PubMed ID: 18482332 [TBL] [Abstract][Full Text] [Related]
14. Potency and in vitro tolerance of organic nitrates: partially denitrated metabolites contribute to the tolerance-devoid activity of pentaerythrityl tetranitrate. Koenig A; Lange K; Konter J; Daiber A; Stalleicken D; Glusa E; Lehmann J J Cardiovasc Pharmacol; 2007 Jul; 50(1):68-74. PubMed ID: 17666918 [TBL] [Abstract][Full Text] [Related]
15. Fetal programming effects of pentaerythritol tetranitrate in a rat model of superimposed preeclampsia. Man AWC; Chen M; Zhou Y; Wu Z; Reifenberg G; Daiber A; Münzel T; Xia N; Li H J Mol Med (Berl); 2020 Sep; 98(9):1287-1299. PubMed ID: 32748067 [TBL] [Abstract][Full Text] [Related]
16. Placental features of fetal vascular malperfusion and infant neurodevelopmental outcomes at 2 years of age in severe fetal growth restriction. Gardella B; Dominoni M; Caporali C; Cesari S; Fiandrino G; Longo S; De Vito GB; Naboni C; Tonduti D; Perotti G; Orcesi S; Spinillo A Am J Obstet Gynecol; 2021 Oct; 225(4):413.e1-413.e11. PubMed ID: 33812813 [TBL] [Abstract][Full Text] [Related]
17. Lack of oxidative stress during sustained therapy with isosorbide dinitrate and pentaerythrityl tetranitrate in healthy humans: a randomized, double-blind crossover study. Keimer R; Stutzer FK; Tsikas D; Troost R; Gutzki FM; Frölich JC J Cardiovasc Pharmacol; 2003 Feb; 41(2):284-92. PubMed ID: 12548090 [TBL] [Abstract][Full Text] [Related]
18. [Quantitative gas chromatography-mass spectrometry determination of pentaerythrityl tetranitrate metabolites pentaerythrityl trinitrate, pentaerythrityl dinitrate and pentaerythrityl in human plasma]. Schütz A; Kötting J; Epple F; Ziegler R; Maier-Lenz H; Stalleicken D Arzneimittelforschung; 1999 Nov; 49(11):891-5. PubMed ID: 10604040 [TBL] [Abstract][Full Text] [Related]
19. Use of biochemical tests of placental function for improving pregnancy outcome. Heazell AE; Whitworth M; Duley L; Thornton JG Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD011202. PubMed ID: 26602956 [TBL] [Abstract][Full Text] [Related]